• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A new low-concentration preparation for mydriasis and cycloplegia.

作者信息

Forman A R

出版信息

Ophthalmology. 1980 Mar;87(3):213-5. doi: 10.1016/s0161-6420(80)35251-2.

DOI:10.1016/s0161-6420(80)35251-2
PMID:7422260
Abstract

This study was designed to evaluate a low-concentration, cycloplegic-mydriatic mixture of phenylephrine and tropicamide in a routine office examination. No clinically significant difference in pupillary dilation was found between the usual instillation of the standard, commercially available phenylephrine 10% and tropicamide 1% drops and the prepared, low-concentration solution. Pupillary dilation was well maintained during direct and indirect ophthalmoscopy and retinoscopy. This solution is easily prepared from readily available drugs, and is simply delivered to the eye using a standard eye dropper. The safety and effectiveness of this low-concentration mixture of phenylephrine and tropicamide make it strongly recommended for routine use.

摘要

相似文献

1
A new low-concentration preparation for mydriasis and cycloplegia.
Ophthalmology. 1980 Mar;87(3):213-5. doi: 10.1016/s0161-6420(80)35251-2.
2
Mydriatic solution for outpatient indirect ophthalmoscopy.门诊间接检眼镜用散瞳溶液。
Arch Ophthalmol. 1980 Sep;98(9):1572-4. doi: 10.1001/archopht.1980.01020040424004.
3
Mydriatic effectiveness of dilute combinations of phenylephrine and tropicamide.
Am J Optom Physiol Opt. 1982 Jul;59(7):580-94. doi: 10.1097/00006324-198207000-00006.
4
A combination solution for routine pupillary dilation.一种用于常规瞳孔扩张的复方溶液。
Optometry. 2006 Jul;77(7):350-3. doi: 10.1016/j.optm.2006.04.107.
5
Effective degree of mydriasis with phenylephrine and tropicamide.去氧肾上腺素与托吡卡胺的散瞳有效程度。
Am J Optom Physiol Opt. 1976 Dec;53(12):774-85. doi: 10.1097/00006324-197612000-00004.
6
Time course of cycloplegia induced by a new phenylephrine-tropicamide combination drug.一种新型去氧肾上腺素-托吡卡胺复方药物引起的睫状肌麻痹的时间进程。
Optom Vis Sci. 1990 May;67(5):352-8. doi: 10.1097/00006324-199005000-00009.
7
A pupillographic evaluation of a phenylephrine HCl 5%-tropicamide 0.8% combination mydriatic.盐酸去氧肾上腺素5%-托吡卡胺0.8%复方散瞳剂的瞳孔描记法评估
J Ocul Pharmacol. 1989 Fall;5(3):199-216. doi: 10.1089/jop.1989.5.199.
8
The comparison of mydriatic effect between two drugs of different mechanism.两种不同作用机制药物散瞳效果的比较。
Korean J Ophthalmol. 2009 Mar;23(1):40-2. doi: 10.3341/kjo.2009.23.1.40. Epub 2009 Mar 9.
9
Pupil dilation evaluation of two mydriatic dosing profiles delivered by the Optejet.评估 Optejet 两种散瞳剂给药方案的瞳孔散大效果。
Ther Deliv. 2023 Feb;14(2):93-103. doi: 10.4155/tde-2022-0061. Epub 2023 May 9.
10
Tropicamide has limited clinical effect on cycloplegia and mydriasis when combined with cyclopentolate and phenylephrine.托吡卡胺与环喷托酯和去氧肾上腺素联合使用时,对睫状肌麻痹和散瞳的临床效果有限。
J AAPOS. 2019 Feb;23(1):30.e1-30.e5. doi: 10.1016/j.jaapos.2018.08.012. Epub 2019 Jan 11.

引用本文的文献

1
Changes in intraocular pressure after pharmacologic pupil dilation.药物性瞳孔散大后眼压的变化。
BMC Ophthalmol. 2012 Sep 27;12:53. doi: 10.1186/1471-2415-12-53.